BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6139950)

  • 21. A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.
    Valyi-Nagy T; Gesser RM; Raengsakulrach B; Deshmane SL; Randazzo BP; Dillner AJ; Fraser NW
    Virology; 1994 Mar; 199(2):484-90. PubMed ID: 8122378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes.
    Gesser RM; Valyi-Nagy T; Fraser NW
    Virology; 1994 May; 200(2):791-5. PubMed ID: 8178461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Herpes simplex virus and macrophages].
    Scieux C
    Pathol Biol (Paris); 1997 Feb; 45(2):159-64. PubMed ID: 9247038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.
    Openshaw H; Asher LV; Wohlenberg C; Sekizawa T; Notkins AL
    J Gen Virol; 1979 Jul; 44(1):205-15. PubMed ID: 227991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuron to neuron transmission of herpes simplex virus. Transport of virus from skin to brainstem nuclei.
    Kristensson K; Nennesmo L; Persson L; Lycke E
    J Neurol Sci; 1982 Apr; 54(1):149-56. PubMed ID: 6281393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity in latent Herpes simplex virus infection.
    Bystrická M; Russ G
    Acta Virol; 2005; 49(3):159-67. PubMed ID: 16178513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two patterns of persistence of herpes simplex virus DNA sequences in the nervous systems of latently infected mice.
    Simmons A; Slobedman B; Speck P; Arthur J; Efstathiou S
    J Gen Virol; 1992 May; 73 ( Pt 5)():1287-91. PubMed ID: 1316947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline.
    Sekizawa T; Openshaw H; Itoyama Y
    J Med Virol; 2003 Jun; 70(2):263-6. PubMed ID: 12696114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The pathophysiology of recurrent herpes simplex virus disease (author's transl)].
    Sundmacher R
    Klin Monbl Augenheilkd; 1977 Apr; 170(4):613-21. PubMed ID: 196135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of latent herpes simplex virus in human vestibular ganglia].
    Suzuki S
    Hokkaido Igaku Zasshi; 1996 Sep; 71(5):561-71. PubMed ID: 8934201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of herpes simplex virus mRNA in latently infected trigeminal ganglion neurons by in situ hybridization.
    Tenser RB; Dawson M; Ressel SJ; Dunstan ME
    Ann Neurol; 1982 Mar; 11(3):285-91. PubMed ID: 6284019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
    J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the in vitro-reactivation of latent herpes simplex virus infection in spinal ganglia: comparison of various immune factors. Brief report.
    von Rheinbaben F; Schneweis KE
    Arch Virol; 1986; 87(3-4):315-9. PubMed ID: 2418807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.
    Rajcáni J; Sabó A; Mucha V; Kostál M; Compel P
    Acta Virol; 1995 Feb; 39(1):37-49. PubMed ID: 7572468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
    Maggioncalda J; Mehta A; Su YH; Fraser NW; Block TM
    Virology; 1996 Nov; 225(1):72-81. PubMed ID: 8918535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1.
    Speck PG; Simmons A
    J Virol; 1991 Aug; 65(8):4001-5. PubMed ID: 1649313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An inquiry into the mechanisms of herpes simplex virus latency.
    Roizman B; Sears AE
    Annu Rev Microbiol; 1987; 41():543-71. PubMed ID: 2825588
    [No Abstract]   [Full Text] [Related]  

  • 39. Herpes simplex virus DNA sequences in the CNS of latently infected mice.
    Cabrera CV; Wohlenberg C; Openshaw H; Rey-Mendez M; Puga A; Notkins AL
    Nature; 1980 Nov; 288(5788):288-90. PubMed ID: 6253827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apparent stability of herpes simplex virus genomes isolated from primary and recurrent infections and dorsal root ganglia in the mouse.
    Blondeau JM; Embil JA; McFarlane ES
    J Med Microbiol; 1988 Dec; 27(4):291-6. PubMed ID: 2848947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.